Home / ENDOV Knockout Cell Lines

ENDOV Knockout Cell Lines

Gene: ENDOV

Official Full Name: endonuclease Vprovided by HGNC

Gene Summary: Enables DNA binding activity; RNA endonuclease activity, producing 5'-phosphomonoesters; and single-stranded RNA binding activity. Predicted to be involved in DNA repair. Located in cytoplasmic stress granule and nucleolus. [provided by Alliance of Genome Resources, Apr 2025]

Get A Quote
Products Background

Products

Catalog Number Product Name Species Gene Passage ratio Mycoplasma testing Price
KO18000 ENDOV Knockout cell line (HeLa) Human ENDOV 1:3~1:6 Negative Online Inquiry
KO18001 ENDOV Knockout cell line (HCT 116) Human ENDOV 1:2~1:4 Negative Online Inquiry
KO18002 ENDOV Knockout cell line (HEK293) Human ENDOV 1:3~1:6 Negative Online Inquiry
KO18003 ENDOV Knockout cell line (A549) Human ENDOV 1:3~1:4 Negative Online Inquiry

Background

ENDOV Gene Knockout Cell Lines are a suite of genetically engineered cell lines designed to facilitate the precise study and manipulation of gene functions by effectively silencing targeted genes. Utilizing the CRISPR-Cas9 genome editing technology, these cell lines serve as invaluable tools for researchers seeking to dissect cellular pathways, investigate gene interactions, and explore the phenotypic consequences of gene loss in various biological contexts.

The primary mechanism by which ENDOV Gene Knockout Cell Lines operate is through the targeted disruption of specific genes, leading to the loss of their expression or function. This is achieved via the introduction of double-strand breaks in the DNA at predefined loci, which subsequently activates the cell’s repair mechanisms to incorporate mutations that effectively knock out the gene of interest. This enables scientists to create in vitro models of disease, validate gene function, and evaluate therapeutic targets, significantly advancing our understanding of both basic biology and disease mechanisms.

The scientific importance of these cell lines is underscored by their broad applications in drug discovery, cancer research, and genetic disorders. They serve as experimental models for preclinical testing, offering insights into drug efficacy and toxicity, thus bridging the gap between lab-based research and clinical application. Researchers can apply these tools to investigate gene functions related to pathways involved in disease progression, fostering innovation in therapeutic interventions.

What sets ENDOV Gene Knockout Cell Lines apart from alternatives, such as traditional RNAi methods or earlier gene-editing techniques, is their high specificity and efficiency, coupled with minimal off-target effects. This results in more reliable and reproducible experimental outcomes, providing a clearer perspective into the roles of individual genes. Researchers can achieve swift and effective gene disruptions, allowing for faster turnaround times in experiments and data generation.

For researchers and clinicians, the value of ENDOV Gene Knockout Cell Lines lies in their robustness and versatility, enabling the creation of tailored models that are crucial for hypothesis-driven investigations. With a focus on advancing genetic understanding, our company boasts immense expertise in developing cutting-edge biological tools, ensuring that ENDOV Gene Knockout Cell Lines represent a significant asset in the biological research arsenal.

Please note that all services are for research use only. Not intended for any clinical use.

Get a free quote

If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.

0

There is no product in your cart.